Kristen Kluska
Stock Analyst at Cantor Fitzgerald
(4.82)
# 464
Out of 4,613 analysts
375
Total ratings
48.1%
Success rate
23.3%
Average return
Main Sectors:
Stocks Rated by Kristen Kluska
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SRPT Sarepta Therapeutics | Maintained: Hold | $21 | $16.53 | +27.04% | 28 | Aug 5, 2026 | |
| ADMA ADMA Biologics | Maintained: Hold | $30 → $12 | $9.86 | +21.70% | 13 | Aug 5, 2026 | |
| ZVRA Zevra Therapeutics | Maintained: Buy | $34 → $25 | $11.40 | +119.30% | 10 | Aug 5, 2026 | |
| RIGL Rigel Pharmaceuticals | Maintained: Hold | $38 → $43 | $40.18 | +7.02% | 14 | Aug 4, 2026 | |
| RARE Ultragenyx Pharmaceutical | Maintained: Buy | $96 | $25.40 | +277.95% | 16 | Aug 4, 2026 | |
| PTCT PTC Therapeutics | Maintained: Buy | $130 | $71.62 | +81.51% | 24 | Jul 30, 2026 | |
| CAPR Capricor Therapeutics | Downgraded: Hold | $62 → $3.5 | $4.13 | -15.25% | 15 | Jul 29, 2026 | |
| CLDX Celldex Therapeutics | Maintained: Buy | $67 → $61 | $41.60 | +46.63% | 26 | Jul 21, 2026 | |
| TSX: EPRX Eupraxia Pharmaceuticals Inc. | Maintained: Buy | $26.61 | $9.33 | +185.23% | 10 | Jul 20, 2026 | |
| DBVT DBV Technologies | Maintained: Buy | $48 | $13.45 | +256.88% | 9 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $63 → $67 | $47.00 | +42.55% | 10 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $3.90 | +182.41% | 5 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | kr 23.00 | kr 7.08 | +224.86% | 1 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $25 | $12.43 | +101.13% | 1 | Jun 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $45.15 | - | 12 | Jun 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $1.49 | +640.74% | 10 | Jun 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $109 | $119.73 | -8.96% | 9 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $8.44 | +89.57% | 2 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 | $0.3001 | +899.67% | 10 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $125 | $77.31 | +61.69% | 17 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $8.77 | +82.44% | 9 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $4.57 | +315.75% | 5 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $6.37 | +198.27% | 19 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $24 | $3.83 | +527.45% | 8 | Mar 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2 | $0.5116 | +290.93% | 9 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $7.17 | +290.79% | 11 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 | $8.39 | +245.65% | 7 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $4.55 | +207.69% | 8 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 → $7 | $0.7146 | n/a | 4 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $3.59 | n/a | 6 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $1.09 | n/a | 3 | Feb 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4 → $20 | $0.9782 | n/a | 2 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $13.27 | n/a | 3 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 | $0.799 | n/a | 3 | Jun 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $30.00 | n/a | 1 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.93 | n/a | 2 | Jun 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.5 → $28 | $0.06 | n/a | 2 | May 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $28 → $20 | $0.0001 | n/a | 3 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 6 | Mar 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.1606 | n/a | 4 | Mar 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4.25 → $10 | $1.39 | n/a | 3 | Dec 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $14 → $11 | $0.5967 | n/a | 2 | Aug 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $180 | $4.19 | n/a | 1 | Dec 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 | $1.26 | n/a | 6 | Sep 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $0.5719 | n/a | 4 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $0.0012 | n/a | 1 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $9 | $0.60 | n/a | 1 | Nov 30, 2020 |
Sarepta Therapeutics
Aug 5, 2026
Maintained: Hold
Price Target: $21
Current: $16.53
Upside: +27.04%
ADMA Biologics
Aug 5, 2026
Maintained: Hold
Price Target: $30 → $12
Current: $9.86
Upside: +21.70%
Zevra Therapeutics
Aug 5, 2026
Maintained: Buy
Price Target: $34 → $25
Current: $11.40
Upside: +119.30%
Rigel Pharmaceuticals
Aug 4, 2026
Maintained: Hold
Price Target: $38 → $43
Current: $40.18
Upside: +7.02%
Ultragenyx Pharmaceutical
Aug 4, 2026
Maintained: Buy
Price Target: $96
Current: $25.40
Upside: +277.95%
PTC Therapeutics
Jul 30, 2026
Maintained: Buy
Price Target: $130
Current: $71.62
Upside: +81.51%
Capricor Therapeutics
Jul 29, 2026
Downgraded: Hold
Price Target: $62 → $3.5
Current: $4.13
Upside: -15.25%
Celldex Therapeutics
Jul 21, 2026
Maintained: Buy
Price Target: $67 → $61
Current: $41.60
Upside: +46.63%
Eupraxia Pharmaceuticals Inc.
Jul 20, 2026
Maintained: Buy
Price Target: $26.61
Current: $9.33
Upside: +185.23%
DBV Technologies
Jul 16, 2026
Maintained: Buy
Price Target: $48
Current: $13.45
Upside: +256.88%
Jul 9, 2026
Maintained: Buy
Price Target: $63 → $67
Current: $47.00
Upside: +42.55%
Jun 25, 2026
Maintained: Buy
Price Target: $11
Current: $3.90
Upside: +182.41%
Jun 25, 2026
Initiated Coverage: Buy
Price Target: kr 23.00
Current: kr 7.08
Upside: +224.86%
Jun 18, 2026
Initiated Coverage: Buy
Price Target: $25
Current: $12.43
Upside: +101.13%
Jun 17, 2026
Upgraded: Buy
Price Target: n/a
Current: $45.15
Upside: -
Jun 16, 2026
Maintained: Buy
Price Target: $11
Current: $1.49
Upside: +640.74%
May 14, 2026
Maintained: Buy
Price Target: $109
Current: $119.73
Upside: -8.96%
May 12, 2026
Maintained: Buy
Price Target: $16
Current: $8.44
Upside: +89.57%
May 12, 2026
Maintained: Buy
Price Target: $3
Current: $0.3001
Upside: +899.67%
May 12, 2026
Maintained: Buy
Price Target: $125
Current: $77.31
Upside: +61.69%
Apr 30, 2026
Maintained: Buy
Price Target: $16
Current: $8.77
Upside: +82.44%
Mar 30, 2026
Maintained: Buy
Price Target: $19
Current: $4.57
Upside: +315.75%
Mar 24, 2026
Maintained: Buy
Price Target: $19
Current: $6.37
Upside: +198.27%
Mar 19, 2026
Maintained: Buy
Price Target: $15 → $24
Current: $3.83
Upside: +527.45%
Mar 10, 2026
Maintained: Hold
Price Target: $2
Current: $0.5116
Upside: +290.93%
Feb 23, 2026
Maintained: Buy
Price Target: $28
Current: $7.17
Upside: +290.79%
Jan 13, 2026
Maintained: Buy
Price Target: $29
Current: $8.39
Upside: +245.65%
Nov 21, 2025
Maintained: Buy
Price Target: $14
Current: $4.55
Upside: +207.69%
Jul 1, 2024
Maintained: Buy
Price Target: $6 → $7
Current: $0.7146
Upside: n/a
May 13, 2024
Rated: Buy
Price Target: n/a
Current: $3.59
Upside: n/a
Feb 4, 2024
Maintained: Buy
Price Target: $6
Current: $1.09
Upside: n/a
Aug 30, 2023
Downgraded: Hold
Price Target: $4 → $20
Current: $0.9782
Upside: n/a
Aug 28, 2023
Reiterated: Buy
Price Target: $23
Current: $13.27
Upside: n/a
Jun 28, 2023
Maintained: Buy
Price Target: $27
Current: $0.799
Upside: n/a
Jun 26, 2023
Reiterated: Buy
Price Target: $17
Current: $30.00
Upside: n/a
Jun 9, 2023
Rated: Hold
Price Target: n/a
Current: $1.93
Upside: n/a
May 15, 2023
Maintained: Buy
Price Target: $3.5 → $28
Current: $0.06
Upside: n/a
Mar 16, 2023
Downgraded: Hold
Price Target: $28 → $20
Current: $0.0001
Upside: n/a
Mar 10, 2023
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Mar 10, 2023
Rated: Hold
Price Target: n/a
Current: $0.1606
Upside: n/a
Dec 21, 2022
Maintained: Hold
Price Target: $4.25 → $10
Current: $1.39
Upside: n/a
Aug 4, 2022
Downgraded: Hold
Price Target: $14 → $11
Current: $0.5967
Upside: n/a
Dec 29, 2021
Initiated Coverage: Buy
Price Target: $180
Current: $4.19
Upside: n/a
Sep 28, 2021
Reiterated: Hold
Price Target: $4
Current: $1.26
Upside: n/a
May 12, 2021
Maintained: Buy
Price Target: $10
Current: $0.5719
Upside: n/a
Mar 2, 2021
Initiated Coverage: Buy
Price Target: $22
Current: $0.0012
Upside: n/a
Nov 30, 2020
Initiated Coverage: Buy
Price Target: $9
Current: $0.60
Upside: n/a